Management and Outcomes of Non-A Non-B Aortic Dissection
- PMID: 35667594
- DOI: 10.1016/j.ejvs.2022.05.037
Management and Outcomes of Non-A Non-B Aortic Dissection
Abstract
Objective: The results of best medical treatment (BMT), endovascular based treatment (EBT), and total arch replacement (TAR) with frozen elephant trunk (FET) treatment in a single centre experience were reported in non-A non-B aortic dissection patients.
Methods: From January 2016 to May 2020, 215 consecutive patients with acute or subacute non-A non-B aortic dissection were enrolled. The primary endpoints were all cause death. Secondary endpoints included follow up adverse aortic event (AE), a composite of the outcomes of dissection related death, rupture, retrograde type A aortic dissection, stent graft induced new entry tear, secondary endoleak, and follow up re-intervention. Kaplan-Meier curves were used to evaluate associations between different treatments and outcomes.
Results: Among the 215 dissection patients, 127 (59.1%) received EBT, 42 (19.5%) received TAR + FET, and the remaining 46 (21.4%) received BMT. Thirty day mortality was higher in patients receiving TAR + FET (7.1%) than in those treated with EBT (1.6%) or BMT (2.2%) (p = .12). However, after a median follow up of 39.1 (27.0 - 50.7) months, no additional death was recorded in the TAR + FET group, while nine (7.3%) patients died in the EBT group and 14 (31.8%) died in the BMT group (p < .001). Specifically, EBT and TAR + FET showed no significant difference in midterm mortality rate, follow up AE, and re-intervention for complicated or uncomplicated dissection patients involving zone 2. For patients with uncomplicated non-A non-B aortic dissection involving zone 2, EBT could profoundly decrease the mortality rate, follow up AE and re-intervention when compared with BMT (p < .010 for all), although this difference was not statistically significant between TAR + FET and BMT. No statistical comparison was performed in patients with zone 1 involvement because of the limited number of patients.
Conclusion: It was demonstrated that EBT or TAR + FET might be a viable strategy for non-A non-B aortic dissection patients.
Keywords: Best medical treatment; Endovascular based treatment; Non-A non-B aortic dissection; Outcomes; Total arch replacement with frozen elephant trunk treatment.
Copyright © 2022 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.
Comment on
-
Current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European Association for Cardio-Thoracic surgery (EACTS) and the European Society for Vascular Surgery (ESVS).Eur J Cardiothorac Surg. 2019 Jan 1;55(1):133-162. doi: 10.1093/ejcts/ezy313. Eur J Cardiothorac Surg. 2019. PMID: 30312382 Review. No abstract available.
-
Acute aortic dissections with entry tear in the arch: A report from the International Registry of Acute Aortic Dissection.J Thorac Cardiovasc Surg. 2019 Jan;157(1):66-73. doi: 10.1016/j.jtcvs.2018.07.101. Epub 2018 Sep 21. J Thorac Cardiovasc Surg. 2019. PMID: 30396735
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
